Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: J Stroke Cerebrovasc Dis. 2020 Jan 13;29(4):104561. doi: 10.1016/j.jstrokecerebrovasdis.2019.104561

Table 4.

Important clinical variables identified by change in PHQ-9 score at follow-up clinic visit by logistic regression.

	Entire Cohort	Stable/Improved PHQ-9^* Score	Worse PHQ-9 Score	Multivariate analysis
	Entire Cohort	Stable/Improved PHQ-9^* Score	Worse PHQ-9 Score	OR	95% CI	P value
Stroke Circulation Location
Anterior or Bilateral	131 (65%)	89 (70%)	42 (57%)	2.03	1.08–3.83	0.029
Posterior Only	70 (35%)	39 (30%)	31 (43%)	2.03	1.08–3.83	0.029
mRS^† at Clinic Follow-Up
0–1	96 (48%)	69 (54%)	27 (37.5%)	2.05	1.11–3.79	0.022
≥2	103 (52%)	58 (46%)	45 (62.5%)	2.05	1.11–3.79	0.022
Use of Antidepressants
Prescribed Antidepressant at Follow-Up	36 (18%)	15 (12%)	21 (29%)	3.45	1.60–7.45	0.002

^*

Patient Health Questionnaire-9

^†

modified Rankin Scale